KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - AccuredReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Goodwill (2018 - 2026)

Twist Bioscience has reported Goodwill over the past 9 years, most recently at $82.2 million for Q1 2026.

  • Quarterly Goodwill fell 4.21% to $82.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $82.2 million through Mar 2026, down 4.21% year-over-year, with the annual reading at $82.2 million for FY2025, 4.21% down from the prior year.
  • Goodwill was $82.2 million for Q1 2026 at Twist Bioscience, roughly flat from $82.2 million in the prior quarter.
  • Over five years, Goodwill peaked at $85.8 million in Q2 2022 and troughed at $82.2 million in Q2 2025.
  • The 5-year median for Goodwill is $85.8 million (2022), against an average of $85.0 million.
  • Year-over-year, Goodwill skyrocketed 7428.82% in 2022 and then dropped 4.21% in 2025.
  • A 5-year view of Goodwill shows it stood at $85.8 million in 2022, then changed by 0.0% to $85.8 million in 2023, then changed by 0.0% to $85.8 million in 2024, then dropped by 4.21% to $82.2 million in 2025, then changed by 0.0% to $82.2 million in 2026.
  • Per Business Quant, the three most recent readings for TWST's Goodwill are $82.2 million (Q1 2026), $82.2 million (Q4 2025), and $82.2 million (Q3 2025).